[Vasoactive intestinal polypeptide (V.I.P)].
D001078:APUD Cells / Q000648:ultrastructure; D007516:Adenoma, Islet Cell / Q000503:physiopathology; D000818:Animals; D001659:Biliary Tract / Q000187:drug effects / Q000502:physiology; D002771:Cholera / Q000503:physiopathology; D003681:Dehydration / Q000503:physiopathology; D003967:Diarrhea / Q000503:physiopathology; D005750:Gastric Juice / Q000378:metabolism; D005768:Gastrointestinal Hormones / Q000502:physiology*; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007008:Hypokalemia / Q000503:physiopathology; D066298:In Vitro Techniques; D007674:Kidney Diseases / Q000503:physiopathology; D008660:Metabolism / Q000187:drug effects; D018377:Neurotransmitter Agents; D010190:Pancreatic Neoplasms / Q000503:physiopathology; D012119:Respiration / Q000187:drug effects; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology / Q000502:physiology*
D005768:Gastrointestinal Hormones; D018377:Neurotransmitter Agents; D014660:Vasoactive Intestinal Peptide
Polipéptido intestinal vasoactivo (V.I.P.).